R1 RCM, Health Catalyst Downgraded as KeyBanc Reviews Health-tech Space
Seeking AlphaApr 11 00:56
Keybanc: Upgraded Certara (CERT.US) rating from wait-and-see to increase holdings, with a target price of $23.00.
Zhitong FinanceApr 10 16:40
Keybanc Upgrades Certara to Overweight, Announces $23 Price Target
BenzingaApr 10 16:38
Certara Analyst Ratings
BenzingaApr 10 16:33
Barclays Remains a Hold on Certara (CERT)
TipRanksApr 10 14:47
Certara Analyst Ratings
BenzingaApr 4 16:52
Jefferies Maintains Hold on Certara, Raises Price Target to $15.5
BenzingaMar 1 20:23
Certara Analyst Ratings
BenzingaMar 1 20:21
Barclays Issues a Hold Rating on Certara (CERT)
TipRanksMar 1 15:55
Certara Analyst Ratings
BenzingaFeb 26 21:35
Certara Analyst Ratings
BenzingaJan 25 22:42
UBS Initiates Coverage On Certara With Neutral Rating, Announces Price Target of $17
BenzingaDec 7, 2023 19:09
Certara Analyst Ratings
BenzingaDec 7, 2023 19:08
Certara Analyst Ratings
BenzingaDec 5, 2023 19:17
BofA Securities Adjusts Price Target on Certara to $20 From $24, Maintains Buy Rating
MT NewswiresOct 20, 2023 22:40
The Latest Analyst Ratings for Certara
BenzingaOct 11, 2023 23:00
Stephens & Co. Reiterates Overweight on Certara, Maintains $20 Price Target
BenzingaOct 11, 2023 20:23
Certara Analyst Ratings
BenzingaOct 11, 2023 20:22
Robert W. Baird Reaffirms Their Hold Rating on Certara (CERT)
TipRanksSep 21, 2023 19:23
Berenberg Bank Keeps Their Buy Rating on Certara (CERT)
TipRanksAug 29, 2023 03:05
No Data
No Data